HYBIO plans to raise no more than 968 million yuan through a private placement for multiple projects and to supplement working capital
I'm PortAI, I can summarize articles.
HYBIO plans to issue A-shares to no more than 35 specific investors, raising no more than 968 million yuan. The issuance price will be 80% of the average price of the 20 trading days prior to the pricing benchmark date. The raised funds will be used for the expansion and construction of peptide drug production lines, green intelligent upgrades, research laboratory upgrades, and to supplement working capital
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments